MAPS Archives

Psychedelics News

MAPS

Breaking News

12 Dec 2023

Breaking News: MAPS Files New Drug Application With FDA for MDMA-Assisted Therapy

Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy....

By Microdose NewsDesk

Industry

14 Sep 2023

MAPS Publishes Results of Successful Phase 3 Trial

In big industry news, MAPS has published the second part of its long-awaited Phase 3 trial of MDMA-assisted therapy for PTSD....

By Microdose NewsDesk

Health & Wellness

19 May 2023

An Introduction to MDMA Therapy

May is Mental Health Awareness Month and Microdose is supporting mental health education with a series of informative articles and resources. Today, we look at MDMA therapy....

By Microdose

Science

17 May 2023

A Look at the History of MDMA Research

MDMA is on the cusp of FDA approval. To help give context, this article dives into the history of MDMA research...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

5 Apr 2023

MAPS Announces Positive Topline Results from Follow-Up Study

More good news from MAPS as it moves its trials through the final approval steps....

By Microdose NewsDesk

Industry

5 Jan 2023

MAPS’ Positive Results Confirmed in Second Phase 3 Trial

MAPS has announced that the second part of its Phase 3 trial of MDMA-assisted therapy for PTSD has confirmed prior positive trial results....

By Microdose NewsDesk

Industry

4 Jan 2023

Top 3 Psychedelic Storylines to Watch in 2023

2022 was a milestone year for the psychedelic industry, and 2023 is shaping up to be an even more paradigm-shifting....

By James Hallifax

Industry

20 Dec 2022

Top 5 Psychedelic Milestones of 2022

2022 was a big year for psychedelic medicine industry, we take a look at the top 5 psychedelic milestones for 2022...

By James Hallifax

Industry

17 Nov 2022

MAPS Completes Second Phase 3 MDMA Trial

MAPS Completes Second Phase 3 "MAPP2" Trial of MDMA-Assisted Therapy for Treatment of PTSD...

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result